Skip to content

Panel Abbaltis 2

by MEDIWISS ANALYTIC GmbH Gesellschaft für angewandte in-vitro Analytik Germany EUDAMED

Ref 0290

EMDN W01020205

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-04251342602902 Basic UDI-DIDate29 Jan 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
AllergyScreen®/AlleisaScreen®
Model / Reference
0290
Primary DI / UDI-DI
04251342602902
Basic UDI-DI
B-04251342602902
EMDN Code
W01020205 Immunoglobulin e - screen
Device Class
Class IVD General
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000004992

Other devices from MEDIWISS ANALYTIC GmbH Gesellschaft für angewandte in-vitro Analytik

See all devices from MEDIWISS ANALYTIC GmbH Gesellschaft für angewandte in-vitro Analytik →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 65788096-cbcb-4d4f-b8de-54a08646fadf 61 fields · synced 23 Oct 2026